Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
closed
BioVex
Biotech Stock Mailbag: Most Important Events for 2012
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Aeterna Zentaris
Alkermes
Amarin
Amgen
Amylin
Aveo Pharmaceutical
BioVex
Celgene
Cell Therapeutics
Celldex
Elan
Eli Lilly
Gilead
JNJ
Keryx
Oncothyreon
ONYX Pharmaceuticals
Pfizer
Pharmasset
Threshold Pharmaceuticals
Vertex
Vical
Vivus
News
Amgen Completes Acquisition of BioVex
Yahoo/PR NewsWire
Amgen
BioVex
M&A
News
Amgen Makes Bet on Viral Skin Cancer Killer
TheStreet.com
Amgen
BioVex
M&A
skin cancer
News
Amgen’s Purchase of Cancer Drugmaker Biovex May Mean More Deals
Bloomberg
Amgen
BioVex
cancer
M&A
News
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Bloomberg
Amgen
BioVex
M&A
Oncovex
News
The 15 most promising biotech companies
Fierce Pharma
Achaogen
Agios Pharmaceuticals
Aileron
biotech
BioVex
Calistoga Pharmaceuticals
Clovis Oncology
Heptares Therapeutics
Ironwood
iZumi Bio
KaloBios
Pacific Biosciences
Portola Pharmaceuticals
Proteon Therapeutics
VaxInnate
Zafgen
»
2 comments
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT